A long-term follow-up report on allogeneic stem cell transplantation for patients with primary refractory acute myelogenous leukemia: impact of cytogenetic characteristics on transplantation outcome

By Fung H.C.   Stein A.   Slovak M.L.   O'Donnell M.R.   Snyder D.S.   Cohen S.   Smith D.   Krishnan A.   Spielberger R.   Bhatia R.   Bhatia S.   Falk P.   Molina A.   Nademanee A.   Parker P.   Rodriguez R.   Rosenthal J.   Sweetman R.   Kogut N.   Sahebi F.   Popplewell L.   Vora N.   Somlo G.   Margolin K.   Chow W.   Smith E.   Forman S.J.  

Biology of Blood and Marrow Transplantation, Vol. 9, Iss. 12, 2003-12 ,pp. : 766-771

Elsevier

Access to resources Recommend Favorite

Severe fludarabine neurotoxicity after reduced intensity conditioning regimen to allogeneic hematopoietic stem cell transplantation: a case report

By  

Clinical Case Reports, Vol. 3, Iss. 7, 2015-07 ,pp. : 650-655

John Wiley & Sons Inc

Access to resources Recommend Favorite

Successful treatment of immediate allogeneic myeloablative hematopoietic stem cell transplantation from a HLA‐mismatched sibling donor for active systemic epstein–barr virus‐positive T‐cell lymphoproliferative disease of childhood following primary acute epstein–barr virus infection

By  

Clinical Case Reports, Vol. 3, Iss. 4, 2015-04 ,pp. : 231-236

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical Utility of Tetramer-Based Immune Monitoring in Allogeneic Stem Cell Transplantation

By Gratama J.W.  

BioDrugs, Vol. 17, Iss. 5, 2003-01 ,pp. : 325-338

Adis International

Access to resources Recommend Favorite

Plerixafor as a salvage mobilization strategy for haploidentical peripheral blood allogeneic stem cell transplantation

By  

Clinical Case Reports, Vol. 2050-0904, Iss. 9, 2015-09 ,pp. : 728-730

John Wiley & Sons Inc

Access to resources Recommend Favorite